Pharmafile Logo
Pharmafocus logo
Advanced Search

Victoza

Showing 12 posts of 42 posts found.

Novo Nordisk's Victoza

Novo’s Victoza beats Bydureon in head-to-head trial

March 4, 2011
Research and Development, Sales and Marketing Alkermes, Amylin, Byureon, Victoza, diabetes, exenatide, lilly, type II diabetes

Bydureon has been outperformed by rival Victoza in a head-to-trial, decimating shares in its co-developer Amylin and Alkermes, the company …

News
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

News
Novo Nordisk's Victoza

Low dose Victoza on track for NICE approval

September 10, 2010
Sales and Marketing NICE, Novo Nordisk, Victoza

Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …

News
Victoza pack

Victoza wins partial NICE recommendation

June 15, 2010
Sales and Marketing NICE, Victoza, diabetes

Novo Nordisk has been given a limited approval for its new type II diabetes treatment in draft guidance issued by …

News

Victoza claims head-to-head victory over Januvia

April 29, 2010
Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza

Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …

News
Byetta

FDA questions delay long-acting Byetta

March 17, 2010
Manufacturing and Production Bydureon, Byetta, Syncria, Victoza

A once-weekly formulation of Eli Lilly and Amylin Pharmaceuticals’ blockbuster diabetes medication Byetta has hit a manufacturing hurdle en route …

News
Victoza pack

Novo to challenge NICE Victoza guidance

February 15, 2010
Sales and Marketing NICE, Novo Nordisk, Victoza

NICE has given a partial green light to Novo Nordisk’s type II diabetes treatment Victoza, backing its use as part …

News

Novo buoyed by insulin portfolio

February 2, 2010
Sales and Marketing 2009 financials, Novo Nordisk, Victoza

Danish pharma company Novo Nordisk managed a double-digit rise in sales and profits in 2009, buoyed by insulin products NovoRapid, …

News
Novo Nordisk HQ

Pancreatitis concerns take shine off Victoza approval

January 28, 2010
Sales and Marketing GLP-1, Novo Nordisk, Victoza

The FDA has approved Novo Nordisk’s Victoza a new once-daily injection for patients with type II diabetes. The drug will …

News

Victoza pill trial begins

January 19, 2010
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II

A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …

News

Victoza launched in UK

July 9, 2009
Sales and Marketing Victoza, diabetes

Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …

News

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009
Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026